‘Pharma Bro’, who drove up anti-HIV drug costs by defrauding investors, gets imprison

The “Pharma Bro” was convicted last year to defraud financial specialists by demonstrating counterfeit record explanations of two failing hedge funds that he ran.

The main drug prices that were used to treat HIV was driven up 50 times by the Martin Shkreli, a previous drug firm executive has been condemned seven-year imprisonment by a New York government court for cheating investors.

The “Pharma Bro” was indicted a year ago to defraud investors by demonstrating counterfeit record explanations of two failing hedge funds that he ran.

As per the PBS reports, the 34-year-old pharmaceutical official, who had gained notoriety for driving up the cost of HIV medicine in 2015 and trolling commentators on the web, cried in the court and apologized to investors and said “I am terribly sorry I lost your trust,” he reportedly said in the court. “You deserve far better.

In spite of the fact that his lawyers requested for tolerance in condemning, the U.S. District Judge Kiyo Matsumoto termed his crimes seriously and handed him the sentence.

Related Posts

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

Three arrested after liquor bottles found at pharma firm

Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources